Timothy Lu: Niche Perfect

Associate Professor, Departments of Electrical Engineering & Computer Science and Biological Engineering, MIT. Age: 35

Written byKerry Grens
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

© MATT KALINOWSKITimothy Lu has straddled different worlds nearly his entire life, having spent the first half of his childhood in the U.S. and the second half in Taiwan. Academically, his experiences have been just as varied. Lu has studied electrical engineering, computer science, synthetic biology, and medicine. This stew of experience has made him into something of a Renaissance bioengineer—a researcher with computational skills, genetics know-how, and clinical knowledge to guide his pursuits. “He has a very unusual background,” says Yoel Fink, director of MIT’s Research Laboratory of Electronics. “There are not many people who have done what he’s done.”

As an undergraduate and master’s student, Lu studied electrical engineering and computer science at MIT, but he got the sense that the big problems in those fields had already been solved. At the same time, around 2003, synthetic biology was blossoming, and Lu wanted in.

For his PhD, Lu joined the lab of synthetic biologist Jim Collins, then at Boston University. Again, Lu was bridging different worlds: his advisor’s lab was at BU, but his degree-granting institutions were across town at Harvard and MIT. Among his accomplishments at the bench, Lu engineered a bacteriophage that could break up biofilms.1 In 2009, collaborating with two fellow graduate students, he used the work to launch a biotech firm, now called Sample6, that uses customized phages to detect ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies